Could lncRNAs be the Missing Links in Control of Mesenchymal Stem Cell Differentiation?. Issue 3 (March 2015)

• Record Type: Journal Article
• Authors: Tye, Coralee E.; Gordon, Jonathan A.R.; Martin‐Buley, Lori A.; Stein, Janet L.; Lian, Jane B.; Stein, Gary S.
• Is Part Of: Journal of cellular physiology. Volume 230:Issue 3(2015:Mar.)
• Page Start: 526
• Page End: 534
• Publication Date: 2015-03
• Subjects: Physiology -- Periodicals; Cell physiology -- Periodicals; 571.6
• DOI: 10.1002/jcp.24834
• Languages: English
• ISSNs: 0021-9541

Abstract

<abstract abstract-type="main" xml:lang="en"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="jcp24834-sec-0001" sec-type="section"> <p>Long suspected, recently recognized, and increasingly studied, non protein‐coding RNAs (ncRNAs) are emerging as key drivers of biological control and pathology. Since their discovery in 1993, microRNAs (miRNAs) have been the subject of intense research focus and investigations have revealed striking findings, establishing that these molecules can exert a substantial level of biological control in numerous tissues. More recently, long ncRNAs (lncRNAs), the lesser‐studied siblings of miRNA, have been suggested to have a similar robust role in developmental and adult tissue regulation. Mesenchymal stem cells (MSCs) are an important source of multipotent cells for normal and therapeutic tissue repair. Much is known about the critical role of miRNAs in biogenesis and differentiation of MSCs however; recent studies have suggested lncRNAs may play an equally important role in the regulation of these cells. Here we highlight the role of lncRNAs in the regulation of mesenchymal stem cell lineages including adipocytes, chondrocytes, myoblasts, and osteoblasts. In addition, the potential for these noncoding RNAs to be used as biomarkers for disease or therapeutic targets is also discussed. J. Cell. Physiol. 230: 526–534, 2015. © 2014 Wiley Periodicals, Inc., A Wiley Company</p> </sec> </abstract>